Version: 1.0.0 | Published: 24 Sep 2026 | Updated: 0 days ago
Documentation
Description:
CSF Olink Explore 3072 data measured for 328 participants as part of the complement biomarker study from the European Platform for Neurodegenerative Diseases (EPND). Measures include the 8 panels of Cardiometabolic, Cardiometabolic II, Inflammation, Inflammation II, Neurology, Neurology II, Oncology, and Oncology II. CSF samples were centrally measured at Sanofi. The complement biomarker study is a substudy of the EPND ATN study.
Coverage
Spatial:
US
Follow Up:
Unknown
Provenance
Temporal
Accrual Periodicity:
Static
Start Date:
01 January 2026
Time Lag:
Not applicable
Accessibility
Access
Access Rights:
See dataset for details. Access data at:
Usage
Resource Creators:
Stephanie Vos;,;Marianna Rizzo;,;Pieter Jelle Visser
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
328
Count
01 January 2026